부산대학교 도서관

BACKGROUND/PURPOSE: Thromboelastographyʼs (TEGʼs) use in pediatric trauma patients is not widely studied. Identifying clotting cascade defects can direct decision making regarding blood product transfusion. METHODS: We performed a single-center retrospective review of all level 1 pediatric trauma patients. Data collected included demographics, diagnoses, Injury Severity Score, intensive care unit length of stay (ICU LOS), mortality, TEG values, and blood products received. We identified TEG values associated with mortality, ICU LOS, and need for blood product transfusion. RESULTS: A total of 237 trauma 1 patients were identified. After exclusions, 148 patients were included for analysis. Most patients were below TEG transfusion cut points. Patients with elevated reaction time, K value, and fibrinolysis at 30 minutes had increased odds of mortality with odds ratios of 1.71 (95% confidence interval [CI], 1.22–2.40), 1.94 (95% CI, 1.23–3.05), and 1.15 (95% CI, 1.03–1.28), respectively. For ICU LOS, elevated reaction time, K value, and fibrinolysis at 30 minutes, α angle, and maximum amplitude demonstrated hazard ratios of 0.76 (95% CI, 0.65–0.88), 0.82 (95% CI, 0.64–1.0), 0.95 (95% CI, 0.88–0.99), 1.05 (95% CI, 1.02–1.08), and 1.04 (95% CI, 1.01–1.06), respectively. There was no association between TEG and blood product transfusion. CONCLUSIONS: Coagulopathic patients based on TEG had higher mortality. All TEG values, as they moved toward transfusion-trigger cut points, were associated with increased mortality.